Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeabilityAndrew J. King, Jeremy S. Caldwell, Natali A. Minassian et al.|Science Translational Medicine|2018Cited by 166
Safety and Pharmacokinetics of 566C80, a Hydroxynaphthoquinone with Anti-Pneumocystis carinii Activity: A Phase I Study in Human Immunodeficiency Virus (HIV)-Infected MenWalter T. Hughes, Mandy Rogers, Wren Kennedy et al.|The Journal of Infectious Diseases|1991Cited by 74
An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with ConstipationPrashant Singh, Lin Chang, Gregory S. Sayuk et al.|Clinical and Experimental Gastroenterology|2024Cited by 10